Free tool
Stocks listed on Nasdaq CM
We cover 137 companies listed on Nasdaq CM. The median market value in the group is $353.03M. Across the group, the median move over the past trading day is −0.09%. 63% of the 136 with a 200-day average trade above it. Price change over the past year runs from −52.3% to +224.3% across the middle 80 percent of the group, with a median of +34.6%.
Other lists in this group
Table
137 of 1,344 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| TGTX | TG Therapeutics, Inc. Common Stock | $8.42B | Mid cap | +92.61% |
| BLTE | Belite Bio, Inc | $6.31B | Mid cap | +144.07% |
| LQDA | Liquidia Corporation | $6.31B | Mid cap | +154.86% |
| DNTH | Dianthus Therapeutics, Inc. | $6.13B | Mid cap | +356.93% |
| CELC | Celcuity Inc. | $4.65B | Mid cap | +90.31% |
| VKTX | Viking Therapeutics, Inc. | $4.01B | Mid cap | +29.15% |
| PLSE | Pulse Biosciences, Inc. | $3.43B | Mid cap | +203.47% |
| IMNM | Immunome, Inc. | $3.34B | Mid cap | +188.94% |
| CLDX | Celldex Therapeutics, Inc. | $3.19B | Mid cap | +79.51% |
| SLS | SELLAS Life Sciences Group, Inc. | $2.77B | Mid cap | +615.10% |
| VRDN | Viridian Therapeutics, Inc. | $2.75B | Mid cap | +30.71% |
| RGC | Regencell Bioscience Holdings Limited | $2.72B | Mid cap | −61.38% |
| AXGN | AxoGen, Inc. Common Stock | $2.68B | Mid cap | +219.58% |
| NKTR | Nektar Therapeutics | $2.52B | Mid cap | +151.95% |
| UFPT | UFP Technologies, Inc. | $2.36B | Mid cap | +41.94% |
| NEO | NeoGenomics, Inc. | $2.26B | Mid cap | +145.34% |
| ESTA | Establishment Labs Holdings Inc. | $2.15B | Mid cap | +70.71% |
| PIII | P3 Health Partners Inc. | $1.98B | Small cap | +26.37% |
| ASTH | Astrana Health, Inc. | $1.92B | Small cap | +23.71% |
| DMRA | Damora Therapeutics, Inc. | $1.89B | Small cap | +804.46% |
| BLFS | BioLife Solutions, Inc. | $1.82B | Small cap | +45.50% |
| FBRX | Forte Biosciences, Inc. | $1.63B | Small cap | +589.87% |
| IMTX | Immatics N.V. | $1.41B | Small cap | +74.63% |
| JBIO | Jade Biosciences, Inc. | $1.39B | Small cap | +168.30% |
| DRTS | Alpha Tau Medical Ltd. | $1.38B | Small cap | +343.92% |
| NUTX | Nutex Health Inc. | $1.34B | Small cap | +118.22% |
| MLTX | MoonLake Immunotherapeutics | $1.32B | Small cap | −71.82% |
| ODTX | Odyssey Therapeutics, Inc. | $1.23B | Small cap | +56.03% |
| AVTX | Avalo Therapeutics, Inc. | $1.10B | Small cap | +112.95% |
| LXRX | Lexicon Pharmaceuticals, Inc. | $1.04B | Small cap | +104.42% |
| IMMX | Immix Biopharma, Inc. | $1.00B | Small cap | +617.86% |
| DBVT | DBV Technologies S.A. | $940.80M | Small cap | +53.00% |
| TALK | Talkspace, Inc. | $870.57M | Small cap | +93.73% |
| ACHV | Achieve Life Sciences, Inc. | $851.00M | Small cap | +177.52% |
| AHG | Akso Health Group | $848.14M | Small cap | −43.10% |
| NVCT | Nuvectis Pharma, Inc. | $816.10M | Small cap | +275.94% |
| AHCO | AdaptHealth Corp. | $771.43M | Small cap | −38.44% |
| MNPR | Monopar Therapeutics Inc. | $763.31M | Small cap | +226.69% |
| DRUG | Bright Minds Biosciences Inc. | $751.90M | Small cap | +76.73% |
| SSII | SS Innovations International, Inc. | $715.38M | Small cap | −50.55% |
| GYRE | Gyre Therapeutics, Inc. | $705.12M | Small cap | −18.00% |
| PROK | ProKidney Corp. | $694.58M | Small cap | −30.12% |
| CBIO | Crescent Biopharma, Inc. | $669.39M | Small cap | +26.46% |
| MDXG | MiMedx Group, Inc. | $644.26M | Small cap | −38.35% |
| VSTM | Verastem, Inc. | $641.19M | Small cap | −20.45% |
| ZURA | Zura Bio Limited | $574.02M | Small cap | +177.31% |
| DCTH | Delcath Systems, Inc. | $569.06M | Small cap | +49.91% |
| OVID | Ovid Therapeutics Inc. | $562.46M | Small cap | +128.57% |
| ENTX | Entera Bio Ltd. | $552.32M | Small cap | +62.76% |
| SRTA | Strata Critical Medical, Inc. | $541.42M | Small cap | +33.62% |
| TOI | Starling Oncology Inc | $512.91M | Small cap | +79.19% |
| CLPT | ClearPoint Neuro, Inc. | $499.35M | Small cap | +53.85% |
| EPRX | Eupraxia Pharmaceuticals Inc. | $490.26M | Small cap | +40.72% |
| RLMD | Relmada Therapeutics, Inc. | $485.35M | Small cap | +579.10% |
| RZLT | Rezolute, Inc. | $485.31M | Small cap | −30.00% |
| QTTB | Q32 Bio Inc. | $481.67M | Small cap | +840.70% |
| OCGN | Ocugen, Inc. | $478.15M | Small cap | +35.58% |
| MCTA | Charming Medical Limited | $445.55M | Small cap | +319.36% |
| BNTC | Benitec Biopharma Inc. | $442.48M | Small cap | +0.16% |
| CMPX | Compass Therapeutics, Inc. | $437.61M | Small cap | −25.91% |
| FENC | Fennec Pharmaceuticals Inc. | $426.77M | Small cap | +34.62% |
| GALT | Galectin Therapeutics Inc. | $418.53M | Small cap | +4.27% |
| XFOR | X4 Pharmaceuticals, Inc. | $412.45M | Small cap | −1.42% |
| IPSC | Century Therapeutics, Inc. | $392.93M | Small cap | +315.53% |
| AGEN | Agenus Inc. | $371.33M | Small cap | +81.72% |
| PALI | Palisade Bio, Inc. | $371.20M | Small cap | +222.73% |
| DMAC | DiaMedica Therapeutics Inc. | $361.30M | Small cap | +12.04% |
| VMD | Viemed Healthcare, Inc. | $355.36M | Small cap | +29.94% |
| SABS | SAB Biotherapeutics, Inc. | $353.03M | Small cap | +83.02% |
| IKT | Inhibikase Therapeutics, Inc. | $347.44M | Small cap | +39.11% |
| ABEO | Abeona Therapeutics Inc. | $343.68M | Small cap | −12.90% |
| PRQR | ProQR Therapeutics N.V. | $331.63M | Small cap | +6.33% |
| RCEL | AVITA Medical, Inc. | $327.52M | Small cap | +133.77% |
| SMTI | Sanara MedTech Inc. | $318.55M | Small cap | +2.09% |
| IRD | Opus Genetics, Inc. | $316.14M | Small cap | +216.67% |
| AMRN | Amarin Corporation plc | $301.43M | Small cap | −7.08% |
| CV | CapsoVision, Inc. | $291.27M | Small cap | +46.97% |
| WHWK | Whitehawk Therapeutics, Inc. | $275.92M | Small cap | +167.40% |
| SRZN | Surrozen, Inc. | $274.56M | Small cap | +107.98% |
| ELDN | Eledon Pharmaceuticals, Inc. | $272.22M | Small cap | +29.84% |
| CGEN | Compugen Ltd. | $271.86M | Small cap | +93.20% |
| GLSI | Greenwich LifeSciences, Inc. | $267.58M | Small cap | +56.21% |
| NAGE | Niagen Bioscience, Inc. | $260.44M | Small cap | −66.22% |
| SLGL | Sol-Gel Technologies Ltd. | $260.05M | Small cap | +261.87% |
| PROF | Profound Medical Corp. | $259.75M | Small cap | +57.30% |
| NERV | Minerva Neurosciences, Inc. | $259.27M | Small cap | +129.11% |
| ACB | Aurora Cannabis Inc. | $253.24M | Small cap | −24.95% |
| AKBA | Akebia Therapeutics, Inc. | $251.20M | Small cap | −69.88% |
| CRDL | Cardiol Therapeutics Inc. | $250.00M | Small cap | +91.07% |
| SY | So-Young International Inc. | $240.91M | Small cap | −38.93% |
| DTIL | Precision BioSciences, Inc. | $234.34M | Small cap | +69.46% |
| ORGO | Organogenesis Holdings Inc. | $225.18M | Small cap | −63.84% |
| IMUX | Immunic, Inc. | $225.00M | Small cap | +92.87% |
| NGEN | NervGen Pharma Corp. | $223.65M | Small cap | −8.30% |
| HITI | High Tide Inc. | $221.43M | Small cap | −30.00% |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | $218.56M | Small cap | +7.93% |
| ORMP | Oramed Pharmaceuticals Inc. | $218.55M | Small cap | +159.19% |
| DERM | Journey Medical Corporation | $212.95M | Small cap | +0.87% |
| CUE | Cue Biopharma, Inc. | $209.58M | Small cap | +16.42% |
| ZJYL | Jin Medical International Ltd. | $208.31M | Small cap | −82.97% |
| ACOG | Alpha Cognition Inc. | $204.93M | Small cap | +14.20% |
| PDEX | Pro-Dex, Inc. | $203.83M | Small cap | +40.31% |
| KRRO | Korro Bio, Inc. | $201.45M | Small cap | −36.61% |
| LUCD | Lucid Diagnostics Inc. | $185.35M | Small cap | −22.96% |
| CNTN | Canton Strategic Holdings, Inc. | $177.69M | Small cap | −55.04% |
| SPRB | Spruce Biosciences, Inc. | $176.69M | Small cap | +721.93% |
| KZIA | Kazia Therapeutics Limited | $166.83M | Small cap | +86.94% |
| TNYA | Tenaya Therapeutics, Inc. | $156.11M | Small cap | −36.71% |
| SPRC | SciSparc Ltd. | $154.36M | Small cap | −82.42% |
| OTLK | Outlook Therapeutics, Inc. | $151.26M | Small cap | −73.76% |
| NRXP | NRx Pharmaceuticals, Inc. | $149.80M | Small cap | +34.11% |
| EQ | Equillium, Inc. | $149.64M | Small cap | +23.56% |
| UNCY | Unicycive Therapeutics, Inc. | $148.74M | Small cap | +27.17% |
| KRMD | KORU Medical Systems, Inc. | $148.21M | Small cap | −24.47% |
| OPRX | OptimizeRx Corporation | $145.98M | Small cap | −55.79% |
| INDP | Indaptus Therapeutics, Inc. | $145.90M | Small cap | −82.19% |
| IMDX | Insight Molecular Diagnostics Inc. | $145.30M | Small cap | +73.39% |
| EMPG | Empro Group Inc | $143.05M | Small cap | +76.60% |
| TLSA | Tiziana Life Sciences Ltd | $138.71M | Small cap | −41.08% |
| HURA | TuHURA Biosciences, Inc. | $135.74M | Small cap | −26.55% |
| INO | Inovio Pharmaceuticals, Inc. | $134.42M | Small cap | −47.15% |
| VTVT | vTv Therapeutics Inc. | $132.73M | Small cap | +106.71% |
| ENGN | enGene Therapeutics Inc. | $130.63M | Small cap | −55.07% |
| PMN | ProMIS Neurosciences, Inc. | $129.67M | Small cap | +9.13% |
| CBUS | Cibus, Inc. | $128.40M | Small cap | +27.27% |
| VANI | Vivani Medical, Inc. | $127.64M | Small cap | +15.98% |
| GNLX | Genelux Corporation | $123.52M | Small cap | −25.00% |
| ANIX | Anixa Biosciences, Inc. | $122.65M | Small cap | +22.20% |
| JYNT | The Joint Corp. | $120.78M | Small cap | −20.19% |
| QUCY | Quantum Cyber N.V. | $115.59M | Small cap | −15.12% |
| COYA | Coya Therapeutics, Inc. | $114.24M | Small cap | −25.76% |
| NAUT | Nautilus Biotechnology, Inc. | $111.99M | Small cap | +33.34% |
| ONCY | Oncolytics Biotech Inc. | $109.10M | Small cap | −19.28% |
| LNSR | LENSAR, Inc. | $106.27M | Small cap | −29.04% |
| BGM | BGM Group Ltd. | $106.17M | Small cap | −96.61% |
| PYPD | PolyPid Ltd. | $103.79M | Small cap | +49.42% |
| MBOT | Microbot Medical Inc. | $102.09M | Small cap | −62.65% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.